Superworth

Embecta EPS EMBC

Diluted earnings per share by quarter and over the last twelve months, from 2020.

Last 12 months, to Jun 30, 2026
$1.47
Latest quarter, Q3 FY26
$0.36
−54% on a year earlier
Fiscal year 2025
$1.62
+20% on the year before

Embecta's earnings per share was $1.47 over the twelve months to Jun 30, 2026, up 3% on a year earlier.

In its latest quarter, Q3 FY26, it was $0.36, down 54% on the same quarter a year before.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025$1.62+20%
FY2024$1.35+12%
FY2023$1.21−69%
FY2022$3.87−47%
FY2021$7.27n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q3 FY26$0.36−54%$1.47
Q2 FY26−$0.07−118%$1.89
Q1 FY26$0.74n/a$2.36
Q4 FY25$0.44+76%$1.62
Q3 FY25$0.78+212%$1.43
Q2 FY25$0.40−20%$0.90
Q1 FY25$0.00−100%$1.00
Q4 FY24$0.25+150%$1.35
Q3 FY24$0.25−4%$1.20
Q2 FY24$0.50+108%$1.21
Q1 FY24$0.35−43%$0.95
Q4 FY23$0.10n/a$1.21

Against its peers

Companies in Medical - Instruments & Supplies nearest Embecta's size, closest first, today.

CompanyEPS, 12 monthsGrowth
EMBCEmbecta$1.47+3% a year
INFUInfuSystem$0.41+78% a year
TCMDTactile Systems Technology$1.08+74% a year
MDXGMimedx$0.04−81% a year
UTMDUtah Medical Products$3.28−12% a year
MOVMovado$1.80+137% a year
PDEXPro DEX$4.11+52% a year
IRMDIradimed$1.79+10% a year
STAAStaar Surgical$0.07
BVSBioventus$0.77
CDRECadre$0.81−14% a year
Peer median$0.94

Where Embecta ranks

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Embecta

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.